WITHDRAWN: Factors associated with receipt of second-line recurrent or metastatic cervical cancer treatment in the United States: A retrospective administrative claims analysis

Kalyani Sonawane; Tara Castellano; Christina Washington; Jie Ting; Andy Surinach; Carol Kirshner; Jagpreet Chhatwal; Turgay Ayer; Kathleen Moore

Gynecologic Oncology Reports (Dec 2022)

WITHDRAWN: Factors associated with receipt of second-line recurrent or metastatic cervical cancer treatment in the United States: A retrospective administrative claims analysis

Kalyani Sonawane,
Tara Castellano,
Christina Washington,
Jie Ting,
Andy Surinach,
Carol Kirshner,
Jagpreet Chhatwal,
Turgay Ayer,
Kathleen Moore

Affiliations

Kalyani Sonawane: Department of Public Health Sciences, College of Medicine, Medical University of South Carolina, Charleston, SC, USA; Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, USA
Tara Castellano: Louisiana State University, Department of Gynecologic Oncology, New Orleans, LA, USA
Christina Washington: Stephenson Cancer Center at the University of Oklahoma HSC, Oklahoma City, OK, USA
Jie Ting: Seagen Inc., Bothell, WA, USA
Andy Surinach: Genesis Research, Hoboken, NJ, USA
Carol Kirshner: Value Analytics Labs, Boston, MA, USA
Jagpreet Chhatwal: Massachusetts General Hospital Institute for Technology Assessment, Harvard Medical School, Boston, MA, USA
Turgay Ayer: Georgia Institute of Technology, Department of Industrial and Systems Engineering, Atlanta, GA, USA; Emory School of Medicine, Atlanta, GA, USA
Kathleen Moore: Stephenson Cancer Center at the University of Oklahoma HSC, Oklahoma City, OK, USA; Corresponding author.

Journal volume & issue: Vol. 44
p. 101101

Abstract

Read online

This article has been withdrawn from this issue: please see Elsevier Policy on Article Withdrawal (http://www.elsevier.com/locate/withdrawalpolicy).This article has been withdrawn at the request of the editor and publisher. It is now available at https://doi.org/10.1016/j.gore.2022.101121The publisher regrets that an error occurred which led to the premature publication of this paper. This error bears no reflection on the article or its authors. The publisher apologizes to the authors and the readers for this unfortunate error.

Published in Gynecologic Oncology Reports

ISSN: 2352-5789 (Online)
Publisher: Elsevier
Country of publisher: United States
LCC subjects: Medicine: Gynecology and obstetrics; Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: http://www.journals.elsevier.com/gynecologic-oncology-reports/

About the journal